drugset / Trial / NCT07829185
Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this research is to observe the effects of using a new combination of drugs to inhibit tumor growth.
Timeline
- Start
- 2026-12
- Primary completion
- 2029-12
- Completion
- 2030-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | 150 mg/m2 | Intravenous |
| Subject | Leucovorin | Small molecule | 400 mg/m2 | Intravenous |
| Subject | Oxaliplatin | Small molecule | 85 mg/m2 | Intravenous |
| Subject | Pentamidine | Unknown | 300 mg | Intravenous |
| Subject | fluorouracil | Small molecule | 2400 mg/m2 | Intravenous |